The Healthcare Technology Report has announced its prestigious list of The Top 25 Healthcare AI Companies of 2025, recognizing the transformative impact of artificial intelligence across the healthcare landscape. Among the awardees is Imagene, a standout innovator in AI-powered precision oncology.

AI continues to revolutionize the pace of medical breakthroughs—handling massive datasets, streamlining workflows, accelerating clinical trials, and optimizing patient care. This year’s awardees are driving a shift towards a more proactive and personalized model of healthcare, using AI responsibly to enhance outcomes for patients and providers alike. Imagene exemplifies these ideals with its cutting-edge approach to oncology research and diagnostics.

Imagene applies advanced AI to uncover complex patterns in biopsy images and omics data, helping pharmaceutical companies, clinical institutions, and life sciences organizations accelerate biomarker discovery, streamline clinical trials, and deliver faster, more accurate cancer diagnostics.

At the center of Imagene’s offering is CanvOI, an Oncology Intelligence Foundation Model developed in collaboration with Oracle. Designed to perform robustly even in limited-data environments, CanvOI powers the OI Suite—a comprehensive platform supporting everything from AI-driven diagnostics to biomarker discovery and drug development. OI Suite enables teams to build and deploy AI-powered models without deep machine learning expertise, allowing partners to scale precision medicine initiatives rapidly and efficiently.

By offering rapid, reliable insights into disease mechanisms and the tumor microenvironment, Imagene is helping advance therapeutic strategies and expand access to precision oncology. With a strong focus on scalability, accessibility, and real-world application, the company is poised to play a major role in the future of cancer research and patient care.